Who we are

CAGE Bio Inc. is a clinical-stage startup exploiting its proprietary deep eutectic ionic liquid platform to develop innovative products for dermatology, inflammation, and immunology.

We believe that systemic exposure to drugs, especially in dermatology,  should be an exception. Our mission is to develop localized treatment options that match the efficacy of the best systemic drugs with the safety of local, topical administration.

CAGE Bio’s proprietary deep eutectic ionic liquids (ILs) enable penetration of small and large molecules such as proteins and nucleic acids across the stratum corneum and deep into the skin.  These ILs have excellent interaction with skin lipids and operate at a molecular scale which makes them superior to all other technologies for skin permeation.